1 Article by H Ümit Kaniskan
The structural diversity of psychedelic drug actions revealed.
Nature communications – March 19, 2025
Summary
Recent insights into psychedelics reveal their diverse actions on the 5-HT2A serotonin receptor, a key player in treating conditions like depression and anxiety. By analyzing various compounds, researchers identified unique molecular interactions, paving the way for new therapies that could offer benefits with fewer side effects.
Abstract
There is currently a resurgence in exploring the utility of classical psychedelics to treat depression, addiction, anxiety disorders, cluster heada...